JAK2 Protein

JAK2 Protein

Introduction

Jak2 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox .infobox-protein"> [@role2015]
| | | [@jak2014]
|---|---| [@cytokinemediated2016]
| Protein Name | Janus Kinase 2 (JAK2) | [@jak2019]
| Gene Symbol | [JAK2](/genes/jak2) | [@microglial2020]
| UniProt ID | [O60674](https://www.uniprot.org/uniprot/O60674) |
| Molecular Weight | ~130 kDa |
| Subcellular Localization | Cytoplasm, associated with membranes |
| Protein Family | Janus kinase family |
| PDB Structure | [4IVB](https://www.ebi.ac.uk/pdbe/entry/pdb/4IVB), [5Y6J](https://www.ebi.ac.uk/pdbe/entry/pdb/5Y6J) |
</div>

Overview

Janus Kinase 2 (JAK2) is a cytoplasmic tyrosine kinase essential for signaling by cytokines and growth factors. It plays a central role in immune regulation, hematopoiesis, and cellular responses to stress.

Structure

JAK2 contains multiple functional domains:

• FERM domain (JH7-JH5): Binds cytokine receptor cytoplasmic domains
• SH2-like domain (JH4-JH3): Regulatory
• Pseudokinase domain (JH2): Autoinhibition, V617F mutation site
• Kinase domain (JH1): Catalytic tyrosine kinase activity

The V617F mutation in JH2 domain causes constitutive activation.

Normal Function

Cytokine Signaling

...

JAK2 Protein

Introduction

Jak2 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox .infobox-protein"> [@role2015]
| | | [@jak2014]
|---|---| [@cytokinemediated2016]
| Protein Name | Janus Kinase 2 (JAK2) | [@jak2019]
| Gene Symbol | [JAK2](/genes/jak2) | [@microglial2020]
| UniProt ID | [O60674](https://www.uniprot.org/uniprot/O60674) |
| Molecular Weight | ~130 kDa |
| Subcellular Localization | Cytoplasm, associated with membranes |
| Protein Family | Janus kinase family |
| PDB Structure | [4IVB](https://www.ebi.ac.uk/pdbe/entry/pdb/4IVB), [5Y6J](https://www.ebi.ac.uk/pdbe/entry/pdb/5Y6J) |
</div>

Overview

Janus Kinase 2 (JAK2) is a cytoplasmic tyrosine kinase essential for signaling by cytokines and growth factors. It plays a central role in immune regulation, hematopoiesis, and cellular responses to stress.

Structure

JAK2 contains multiple functional domains:

• FERM domain (JH7-JH5): Binds cytokine receptor cytoplasmic domains
• SH2-like domain (JH4-JH3): Regulatory
• Pseudokinase domain (JH2): Autoinhibition, V617F mutation site
• Kinase domain (JH1): Catalytic tyrosine kinase activity

The V617F mutation in JH2 domain causes constitutive activation.

Normal Function

Cytokine Signaling

• Associates with cytokine receptors (not receptor tyrosine kinases)
• Transphosphorylates and activates upon ligand binding
• Phosphorylates STAT transcription factors
• Initiates gene expression programs

Key Cytokines Using JAK2

• Interleukin-6 family cytokines
• Interferon-α/β
• Erythropoietin (EPO)
• Thrombopoietin (TPO)
• Granulocyte colony-stimulating factor (G-CSF)

Role in Neurodegeneration

Alzheimer's Disease

• JAK2/STAT3 hyperactivated in AD brain
• Mediates inflammatory responses to [Aβ](/proteins/amyloid-beta) plaques
• Contributes to microglial activation
• Modulates neuronal survival

Parkinson's Disease

• Elevated in substantia nigra pars compacta
• Contributes to neuroinflammation
• Involved in glial responses
• Dopaminergic neuron vulnerability

Amyotrophic Lateral Sclerosis

• Dysregulated JAK2/STAT3 in ALS models
• Activated in motor [neurons](/entities/neurons) and glia
• Contributes to inflammation

Multiple Sclerosis

• Central to CNS autoimmune inflammation
• JAK inhibitors show promise in trials

Therapeutic Targeting

JAK Inhibitors

| Drug | Specificity | Clinical Use |
|------|-------------|--------------|
| Ruxolitinib | JAK1/JAK2 | Myelofibrosis, GVHD |
| Tofacitinib | JAK1/JAK2/JAK3 | Rheumatoid arthritis |
| Baricitinib | JAK1/JAK2 | Rheumatoid arthritis |
| Fedratinib | JAK2 | Myelofibrosis |

CNS Challenges

• [Blood-brain barrier](/entities/blood-brain-barrier) penetration
• Systemic immunosuppression
• Balancing inflammation vs. function

Key Publications

Ben H, et al. (2019). "JAK2 in neuroinflammation and AD." J Neuroinflammation. PMID: 30654698(https://pubmed.ncbi.nlm.nih.gov/30654698/)

Liu J, et al. (2018). "JAK2/STAT3 neuroprotection." Movement Disorders. PMID: 29578456(https://pubmed.ncbi.nlm.nih.gov/29578456/)

See Also

• [JAK2 Gene](/genes/jak2)
• [STAT3 Gene](/genes/stat3)
• [JAK-STAT Pathway](/mechanisms/jak-stat-pathway)
• [Cytokine Signaling](/mechanisms/cytokine-signaling)
• [Neuroinflammation Pathway](/mechanisms/neuroinflammation)

External Links

• [UniProt: JAK2](https://www.uniprot.org/uniprot/O60674)
• [PDB: JAK2](https://www.ebi.ac.uk/pdbe/entry/pdb/4IVB)
• [Human Protein Atlas](https://www.proteinatlas.org/ENSG00000096968-JAK2)
• [Kinase Database: JAK2](https://www.kinasedb.org/node/P06493)

Background

The study of Jak2 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

References

[Unknown, JAK2-STAT3 signaling in neuroinflammation (2010) (2010)](https://pubmed.ncbi.nlm.nih.gov/20051302/)

[Unknown, Role of JAK2 in Alzheimer's disease (2015) (2015)](https://pubmed.ncbi.nlm.nih.gov/25881956/)

[Unknown, JAK2 inhibition protects against neuronal death (2014) (2014)](https://pubmed.ncbi.nlm.nih.gov/24792312/)

[Unknown, Cytokine-mediated JAK2-STAT3 activation in PD (2016) (2016)](https://pubmed.ncbi.nlm.nih.gov/27272163/)

[Unknown, JAK inhibitors as therapeutic agents for neurodegeneration (2019) (2019)](https://pubmed.ncbi.nlm.nih.gov/31199247/)

[Unknown, Microglial JAK2-STAT3 in AD pathogenesis (2020) (2020)](https://pubmed.ncbi.nlm.nih.gov/32847651/)